تُقدّم أمراض القلب الروماتيزمية لدى المريض المصاب بقلس الأبهر اعتبارات إدارية محددة، لا سيما عند وجود خلل وظيفة البطين الأيسر أو قصور القلب.
As yet, no medical therapy has been shown to slow the progression of AR, and so treatment is predominantly targeted at symptom relief and treatment of underlying left ventricular dysfunction and heart failure.
Treatment with angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and β-blockers has been shown to be beneficial in large population cohort studies in patients with AR, particularly those with left ventricular dysfunction.
DOI: 10.1161/CIR.0000000000000921
View source ↗